Easy access to the latest innovation in precision medicine with IMMUNOSCORE®

Immunity Assessed - Personalized Treatment

Immunoscore Access Program (ISAP)

Immunoscore Access Program is a special commercial initiative to allow oncologists gain easy access to our test and benefit from its clinical utility in the management of early stage colon cancer.

isap-visuel-1
Take advantage immediately of our new ISAP program for one year without volume commitment.

Maximize your colon cancer patients’ chances of survival by using IMMUNOSCORE®.

HalioDx is committed to provide innovative diagnostics solutions to those who need it most.

Sign up for the Immunoscore Access Program in localized colon cancer

To find out more about the Immunoscore Access Program, please fill the form below